The Craneware Group

Overview

The Craneware Group, founded in 1999 and based in the United Kingdom, operates within the healthcare software sector, focusing on solutions that enhance financial sustainability for healthcare organizations. With a workforce of 501 to 1,000 employees, the company emphasizes the optimization of pharmacy revenue cycles, particularly in relation to the 340B Drug Pricing Program. Their published content highlights the critical link between pharmacy revenue management and compliance with 340B requirements, which allows eligible healthcare providers to purchase medications at discounted rates. The company advocates for the integration of financial processes to maximize revenue capture from medications while ensuring compliance, thereby improving cash flow and operational efficiency for healthcare systems. Their approach includes fostering collaboration between pharmacy and finance departments and leveraging technology to mitigate labor costs and enhance patient care. The Craneware Group's insights reflect a commitment to addressing the financial pressures faced by healthcare organizations, aiming to support the delivery of high-quality care in a challenging economic landscape.

Industry